Correlation Between VistaGen Therapeutics and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and Cue Biopharma, you can compare the effects of market volatilities on VistaGen Therapeutics and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and Cue Biopharma.
Diversification Opportunities for VistaGen Therapeutics and Cue Biopharma
-0.26 | Correlation Coefficient |
Very good diversification
The 3 months correlation between VistaGen and Cue is -0.26. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and Cue Biopharma go up and down completely randomly.
Pair Corralation between VistaGen Therapeutics and Cue Biopharma
Given the investment horizon of 90 days VistaGen Therapeutics is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, VistaGen Therapeutics is 2.5 times less risky than Cue Biopharma. The stock trades about -0.07 of its potential returns per unit of risk. The Cue Biopharma is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 286.00 in Cue Biopharma on September 3, 2024 and sell it today you would lose (164.00) from holding Cue Biopharma or give up 57.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
VistaGen Therapeutics vs. Cue Biopharma
Performance |
| Timeline |
| VistaGen Therapeutics |
| Cue Biopharma |
VistaGen Therapeutics and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VistaGen Therapeutics and Cue Biopharma
The main advantage of trading using opposite VistaGen Therapeutics and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| VistaGen Therapeutics vs. Milestone Pharmaceuticals | VistaGen Therapeutics vs. Seres Therapeutics | VistaGen Therapeutics vs. DiaMedica Therapeutics | VistaGen Therapeutics vs. Lyra Therapeutics |
| Cue Biopharma vs. Milestone Pharmaceuticals | Cue Biopharma vs. Seres Therapeutics | Cue Biopharma vs. DiaMedica Therapeutics | Cue Biopharma vs. Lyra Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |